Delisting risk
ICU · NASDAQ · Biotechnology

SeaStar Medical (ICU)

Builds extracorporeal immunomodulation cartridges for acute kidney injury care.

$2.90
At close−0.09 (−2.87%)

Breakdown13F · 13D/G · Form 4

Institutions17 holders · as of Mar 31, 20262.99%131.6K shares
Insiders10 holders · as of Aug 19, 202613.18%581.0K shares
Otherremainder83.83%3.69M shares

4.41M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (4.41M in the company's Sep 3, 2026 report, 2.84M elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Mitchell P. KopinInsider
10.06%443,25313Gfiled May 13, 2026
Opportunity Master Fund, SPC – Segregated Master Portfolio BInstitution
6.32%278,43613Gfiled May 11, 2026
Geode Capital Management, LLCInstitution
1.26%55,64213Fas of Mar 31, 2026
Eric SchlorffInsiderofficer: Chief Executive Officer
1.14%50,140Form 4filed Jul 2, 2026
Vanguard Capital Management LLCInstitution
0.65%28,79113Fas of Mar 31, 2026
Kevin ChungInsiderofficer: Chief Medical Officer
0.64%28,021Form 4filed Jul 2, 2026
Jane Street Group, LLCInstitution
0.63%27,96013Fas of Mar 31, 2026
John NeumanInsiderdirector
0.37%16,200Form 4filed Jul 2, 2026
Vanguard Fiduciary Trust CoInstitution
0.31%13,69213Fas of Mar 31, 2026
Kenneth van HeelInsiderdirector
0.27%11,940Form 4filed Jul 2, 2026
Jennifer A. BairdInsiderdirector
0.24%10,620Form 4filed Jul 2, 2026
Bradford K. TowneInsiderofficer: Principal Accounting Officer
0.21%9,050Form 4filed Feb 10, 2026
Bernadette N. VincentInsiderdirector
0.19%8,200Form 4filed Jul 2, 2026
Michael MessingerInsiderofficer: Chief Financial Officer
0.06%2,500Form 4filed Aug 19, 2026
PNC Financial Services Group, Inc.Institution
0.04%1,74813Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution
0.03%1,39513Fas of Mar 31, 2026
David A. GreenInsiderofficer: Chief Financial Officer
0.02%1,032Form 4filed Sep 9, 2024
BlackRock, Inc.Institution
0.02%91313Fas of Mar 31, 2026
UBS Group AGInstitution
0.02%79313Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution
0.01%23013Fas of Mar 31, 2026
Newedge Advisors, LLCInstitution
0.00%17613Fas of Mar 31, 2026
Vanguard Global Advisers, LLCInstitution
0.00%16513Fas of Mar 31, 2026
TD Waterhouse Canada Inc.Institution
0.00%2213Fas of Mar 31, 2026
Morgan StanleyInstitution
0.00%2013Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.00%1413Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

17 holders · 131.6K shares

HolderShares% outstandingChg q/qFiled
Geode Capital Management, LLC55.6K1.26%May 15, 2026
Vanguard Capital Management LLC28.8K0.65%May 15, 2026
Jane Street Group, LLC28.0K0.63%May 12, 2026
Vanguard Fiduciary Trust Co13.7K0.31%May 8, 2026
PNC Financial Services Group, Inc.1.7K0.04%May 8, 2026
Tower Research Capital LLC (TRC)1.4K0.03%May 15, 2026
BlackRock, Inc.9130.02%May 13, 2026
UBS Group AG7930.02%May 5, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Mitchell P. Kopin9.99%443.3K13GMay 13, 2026
Opportunity Master Fund, SPC – Segregated Master Portfolio Bincl. Capital LLC, Khatri6.60%13GNov 14, 2024
Ayrton Capital LLC6.52%278.4K13GMay 11, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 18, 2026
Michael Messingerofficer: Chief Financial Officer
Purchase750$3.272,500
Dec 19, 2025
Jennifer A. Bairddirector
Purchase4,200$0.235136,200
Dec 9, 2025
Michael Messingerofficer: Chief Financial Officer
Purchase14,500$0.351617,500

CongressHouse and Senate disclosures

Not reported.